Skip to main content
Equibles

Anatoly Dritschilo

CTO

Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Anatoly Dritschilo

Anatoly Dritschilo is recorded as CTO at Shuttle Pharmaceuticals Holdings, Inc. (SHPH). Shuttle Pharmaceuticals Holdings, Inc. reported in an 8-K filed March 31, 2025 that Anatoly Dritschilo was appointed Chief Scientific Officer, effective March 30, 2025.

“Effective March 30, 2025, the Company's Board of Directors approved the appointment of Christopher Cooper to the position of interim Chief Executive Officer and Anatoly Dritschilo, M.D., to the position of Chief Scientific Officer.”
Shuttle Pharmaceuticals Holdings, Inc. Form 8-K, filed March 31, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Shuttle Pharmaceuticals Holdings, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.